Cargando…

Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma

Background: Corneal ulcer could be a major source of distress in small animals, with many contributing agents. In recent years, few studies evaluated the efficacy of platelet-rich plasma (PRP) in healing corneal ulcers. Aim: This study aimed to assess the ability of subconjunctival injection of auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Farghali, Haithem A., AbdElKader, Naglaa A., AbuBakr, Huda O., Ramadan, Eman S., Khattab, Marwa S., Salem, Noha Y., Emam, Ibrahim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012907/
https://www.ncbi.nlm.nih.gov/pubmed/33816586
http://dx.doi.org/10.3389/fvets.2021.641265
_version_ 1783673460363362304
author Farghali, Haithem A.
AbdElKader, Naglaa A.
AbuBakr, Huda O.
Ramadan, Eman S.
Khattab, Marwa S.
Salem, Noha Y.
Emam, Ibrahim A.
author_facet Farghali, Haithem A.
AbdElKader, Naglaa A.
AbuBakr, Huda O.
Ramadan, Eman S.
Khattab, Marwa S.
Salem, Noha Y.
Emam, Ibrahim A.
author_sort Farghali, Haithem A.
collection PubMed
description Background: Corneal ulcer could be a major source of distress in small animals, with many contributing agents. In recent years, few studies evaluated the efficacy of platelet-rich plasma (PRP) in healing corneal ulcers. Aim: This study aimed to assess the ability of subconjunctival injection of autologous PRP in the treatment of corneal ulcers in dogs and cats as well as estimate the expression of matrix metalloproteinase (MMP)-2, MMP-9, and oxidative stress biomarkers in these patients. Methods: A total number of 28 animals (16 cats and 12 dogs) were enrolled in this study. Each animal was subjected to clinical, neurologic, and ophthalmic examinations where the type of ulcer was documented. Tear samples were collected for evaluation of oxidative biomarkers and MMPs; conjunctival swabs were taken to identify the involved organism. PRP was prepared from each animal and given as subconjunctival injection; numbers of injections were done according to case response. Clinical follow-up was done and documented for each case. Results: In cat patients, female and Persian cats were most affected; unilateral and superficial ulcers were most recorded. In male dogs, unilateral, and superficial ulcers were most recorded. FHV-1 was most identified in cats, while Staphylococcus aureus was most identified in dogs. Numbers of injections needed to achieve healing were recorded, with 50% of dogs needing two injections with 1-week intervals and 50% of cats needed three injections with 1-week intervals. Alterations in both oxidative biomarkers and MMPs were recorded in affected animals. Conclusion: The use of autologous PRP as a subconjunctival injection in treating corneal ulcers in dogs and cats is effective. The number of injections is the case and corneal ulcer type-dependent. Clinical Significance: Autologous PRP as a subconjunctival injection in treating corneal ulcer is a relatively cheap, safe method and can be done in the clinical setting.
format Online
Article
Text
id pubmed-8012907
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80129072021-04-02 Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma Farghali, Haithem A. AbdElKader, Naglaa A. AbuBakr, Huda O. Ramadan, Eman S. Khattab, Marwa S. Salem, Noha Y. Emam, Ibrahim A. Front Vet Sci Veterinary Science Background: Corneal ulcer could be a major source of distress in small animals, with many contributing agents. In recent years, few studies evaluated the efficacy of platelet-rich plasma (PRP) in healing corneal ulcers. Aim: This study aimed to assess the ability of subconjunctival injection of autologous PRP in the treatment of corneal ulcers in dogs and cats as well as estimate the expression of matrix metalloproteinase (MMP)-2, MMP-9, and oxidative stress biomarkers in these patients. Methods: A total number of 28 animals (16 cats and 12 dogs) were enrolled in this study. Each animal was subjected to clinical, neurologic, and ophthalmic examinations where the type of ulcer was documented. Tear samples were collected for evaluation of oxidative biomarkers and MMPs; conjunctival swabs were taken to identify the involved organism. PRP was prepared from each animal and given as subconjunctival injection; numbers of injections were done according to case response. Clinical follow-up was done and documented for each case. Results: In cat patients, female and Persian cats were most affected; unilateral and superficial ulcers were most recorded. In male dogs, unilateral, and superficial ulcers were most recorded. FHV-1 was most identified in cats, while Staphylococcus aureus was most identified in dogs. Numbers of injections needed to achieve healing were recorded, with 50% of dogs needing two injections with 1-week intervals and 50% of cats needed three injections with 1-week intervals. Alterations in both oxidative biomarkers and MMPs were recorded in affected animals. Conclusion: The use of autologous PRP as a subconjunctival injection in treating corneal ulcers in dogs and cats is effective. The number of injections is the case and corneal ulcer type-dependent. Clinical Significance: Autologous PRP as a subconjunctival injection in treating corneal ulcer is a relatively cheap, safe method and can be done in the clinical setting. Frontiers Media S.A. 2021-03-18 /pmc/articles/PMC8012907/ /pubmed/33816586 http://dx.doi.org/10.3389/fvets.2021.641265 Text en Copyright © 2021 Farghali, AbdElKader, AbuBakr, Ramadan, Khattab, Salem and Emam. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Farghali, Haithem A.
AbdElKader, Naglaa A.
AbuBakr, Huda O.
Ramadan, Eman S.
Khattab, Marwa S.
Salem, Noha Y.
Emam, Ibrahim A.
Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title_full Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title_fullStr Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title_full_unstemmed Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title_short Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
title_sort corneal ulcer in dogs and cats: novel clinical application of regenerative therapy using subconjunctival injection of autologous platelet-rich plasma
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012907/
https://www.ncbi.nlm.nih.gov/pubmed/33816586
http://dx.doi.org/10.3389/fvets.2021.641265
work_keys_str_mv AT farghalihaithema cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT abdelkadernaglaaa cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT abubakrhudao cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT ramadanemans cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT khattabmarwas cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT salemnohay cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma
AT emamibrahima cornealulcerindogsandcatsnovelclinicalapplicationofregenerativetherapyusingsubconjunctivalinjectionofautologousplateletrichplasma